Premium
Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study
Author(s) -
Jabbour Elias,
Patel Keyur,
Jain Nitin,
Duose Dzifa,
Luthra Rajyalakshmi,
Short Nicholas J.,
Zugmaier Gerhard,
San Lucas Anthony,
Velasco Kelly,
Tran Qui,
Zaman Faraz,
Konopleva Marina,
Kantarjian Hagop
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26281
Subject(s) - blinatumomab , medicine , post hoc analysis , minimal residual disease , refractory (planetary science) , clinical trial , oncology , phases of clinical research , leukemia , lymphoblastic leukemia , biology , astrobiology